Siemens Medical's first domestic high-end flagship ultrasound system Yinshan was put into production

SHANGHAI, Jan. 19, 2022 /PRNewswire/ -- Today, Siemens Healthcare's first domestic high-end flagship ultrasound system, ACUSON Sequoia Silver (Chinese name: Yinshan), officially rolled off production at its R&D and production facility in Shanghai. Silver Fir obtained its registration certificate on November 19, 2021 and a production license on January 13, 2022, and is expected to be shipped and delivered within one week at the earliest. Inheriting the advantages of the ACUSON Sequoia family series, Yinshan will respond more timely and quickly to Chinese doctors and patients.

Siemens Medical's first domestic high-end flagship ultrasound system Yinshan was put into production

Silver Fir is equipped with the industry's cutting-edge BioAcoustic™ bioacoustic platform, breaking the limitations of traditional ultrasound, fundamentally solving the problem of differences between patients, devices and operators, for patients with different sizes, to ensure the consistency and clarity of the image InFocus full focus coherent imaging, providing ultra-high detail resolution, to achieve uniform and consistent images in the whole field, to help doctors shorten the scanning time, reduce the patient waiting time Color Flash Suppression clear blood flow patent technology clearly shows the patient's real-time blood flow, easy for doctors to accurately determine the patient's blood flow status Unique gesture sense design easy to achieve instant activation to start scanning spectrum zero key optimization function to help doctors simplify the workflow, improve diagnosis and treatment efficiency, and spend more time on patient communication At the same time, Yinshan is also equipped with many advanced functions, such as comprehensive elastography and leading contrast imaging and a rich probe group, providing a comprehensive solution for the majority of Chinese patients.

"In response to the needs of Chinese customers, Siemens Healthcare actively promotes the local production of ultrasound equipment Today, we are very happy to see Yinshan roll off the production line at the Shanghai base, which is another powerful example of the company's root in China and long-term service to China", said Mr. Ma Jinxian, general manager of the ultrasound division of Siemens Healthcare Greater China, "In the research and development and design process of the Yinshan system, we fully considered the feedback of Chinese users and the current challenges of ultrasound examination, and look forward to this domestic high-end flagship of Siemens Medical." Ultrasound diagnostic equipment brings a new experience and enhanced diagnostic value to the majority of doctors"

Siemens Healthcare Shanghai R&D and production base was established in 1992, with the ability to develop and produce CT, X-ray machine, mobile C-shaped arm and other imaging diagnosis and treatment systems Yinshan local production project, from the project start to the equipment off-line, Siemens medical team took less than a year, fully demonstrating Siemens Healthcare China's determination and ability to further promote localization and accelerate localization and upgrade.

About Siemens Healthcare

Headquartered in Erlangen, Germany, Siemens Healthers (Frankfurt Stock Exchange: SHL) is a leading medical technology company committed to the continuous development of its product and service portfolio, including ARTIFICIAL-based applications and digital products that play an increasingly important role in the development of next-generation medical technologies, which will further strengthen the company's foundation in the fields of in vitro diagnosis, image-guided treatment, in vivo diagnosis and new cancer diagnosis, while Siemens Healthcare offers a wide range of services and solutions. In FY2021 (ending September 30, 2021), Siemens Healthcare has generated total revenue of €18 billion and adjusted profit of €3.1 billion and employs approximately 66,000 people worldwide.